Inhaled vilanterol trifenatate/fluticasone furoate increases maximum diaphragm contraction in severe COPD
Jenny Jagers, Michael Ji, Malcolm Johnson, Eric Wilde, Paul Easton
European Respiratory Journal 2014 44: P3538; DOI:
Jenny Jagers
1Lethbridge Regional Hospital, University of Calgary, Calgary, AB, Canada
Michael Ji
1Lethbridge Regional Hospital, University of Calgary, Calgary, AB, Canada
Malcolm Johnson
2GlaxoSmithKline, Stockley Park West, Uxbridge, Middlesex, United Kingdom
Eric Wilde
1Lethbridge Regional Hospital, University of Calgary, Calgary, AB, Canada
Paul Easton
1Lethbridge Regional Hospital, University of Calgary, Calgary, AB, Canada
Vol 44 Issue Suppl 58
Table of Contents
Inhaled vilanterol trifenatate/fluticasone furoate increases maximum diaphragm contraction in severe COPD
Jenny Jagers, Michael Ji, Malcolm Johnson, Eric Wilde, Paul Easton
European Respiratory Journal Sep 2014, 44 (Suppl 58) P3538;